Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Prevention of osteoporosis in pharmacies

  • At: 2010 FIP Congress in Lisbon (Portugal)
  • Type: Poster
  • By: MILOVANOVIC-IVANCIC, Nada (The Community Pharmacy Ivancic and son, Belgrade, Yugoslavia)
  • Co-author(s): Andjelic, Vera (The Community Pharmacy Ivancic and son, BELGRADE, Serbia)
    Bjelogrlic, Ana (The Community Pharmacy Ivancic and son, BELGRADE, Serbia)
    Tadic, Ivana (Institute for Social Pharmacy and Pharmacy Legislation, Faculty of Pharmacy, BELGRADE, Serbia)
    Milosevic, Andrijana (Institute for Social Pharmacy and Pharmacy Legislation, Faculty of Pharmacy, BELGRADE, Serbia)
  • Abstract:

    Background information: Osteoporosis is defined as a quantitative and qualitative deterioration of bone tissue leading to increased risk of fracture. Pharmacies can offer specific intervention as unpaid measuring of bone mass density (BMD). In order to identify patients who need adequate prevention or osteoporosis treatment we analyzed the T-score

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses